Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

KALA

KALA BIO, Inc.

CIK 0001479419 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$1.35
↓ 0.04 (-2.88%)
as of Jul 9, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 3/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership; Risks: Fundamentals, Technicals; Excluded: Options (no data)

Key stats

Market Cap
$25.10M
P/E Ratio
-1.28
EPS
-3.31
Dividend Yield
Not covered
52W Position
6%
Beta
1.93

Valuation multiples

Fwd P/E
Not covered
PEG
0.00
P/B
2.33
P/S
Not covered
EV/Revenue
Not covered
ROE
-182.6%
Valuation data covers 8,503/9,463 US-listed stocks (89.9%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 6%
$0.07$20.60

Latest Financials

2025-12-31 FY
Revenue
$0.00
Net Income
-$26.98M
Total Assets
$9.49M
Free Cash Flow
–

Recent news